Botulinum neurotoxin: a marvel of protein design

M Montal - Annual review of biochemistry, 2010 - annualreviews.org
Botulinum neurotoxins (BoNTs), a family of bacterial proteins produced by the anaerobic
bacterium Clostridium botulinum, are potent blockers of synaptic transmission in peripheral …

[HTML][HTML] Substrate binding mode and its implication on drug design for botulinum neurotoxin A

D Kumaran, R Rawat, SA Ahmed… - PLoS …, 2008 - journals.plos.org
botulinum neurotoxins, the causative agents of botulism, block the neurotransmitter release
by specifically cleaving one of the three SNARE proteins … them, botulinum neurotoxin type A (…

[HTML][HTML] Structural insights into rational design of single-domain antibody-based antitoxins against botulinum neurotoxins

K Lam, JM Tremblay, E Vazquez-Cintron, K Perry… - Cell Reports, 2020 - cell.com
Botulinum neurotoxin (BoNT) is one of the most acutely lethal toxins known to humans, and
… Guided by this knowledge, we design heterodimeric VHHs by connecting two neutralizing …

Strategies to design inhibitors of Clostridium botulinum neurotoxins

S Cai, BR Singh - … Drug Targets (Formerly Current Drug Targets …, 2007 - ingentaconnect.com
… Clostridial botulinum neurotoxins are the … Botulinum neurotoxins (BoNTs) are a group of
proteins produced by different strains of Clostridium botulinum, and are responsible for botulism

Strategies to counteract botulinum neurotoxin A: nature's deadliest biomolecule

L Lin, ME Olson, LM Eubanks… - Accounts of chemical …, 2019 - ACS Publications
… (8,9) Cytosolic BoNT/A LC cleaves SNAP-25 (synaptosomal-associated protein of 25-kDa),
a SNARE (soluble N-ethylmaleimide sensitive factor attachment protein receptor) protein

[HTML][HTML] Engineering botulinum neurotoxins for enhanced therapeutic applications and vaccine development

C Rasetti-Escargueil, MR Popoff - Toxins, 2020 - mdpi.com
… In this review, we summarize the current understanding of Botulinum neurotoxin (BoNT) …
BoNTs belong to a family of neurotoxins which are produced by various Clostridium botulinum

Current strategies for designing antidotes against botulinum neurotoxins

K Patel, S Cai, BR Singh - Expert Opinion on Drug Discovery, 2014 - Taylor & Francis
… Introduction: Botulinum neurotoxins (BoNTs) are proteins responsible for the deadly paralytic
disease botulism. Extreme toxicity, ease of production and lack of antidotes against BoNT …

Novel native and engineered botulinum neurotoxins

L Steward, MF Brin, A Brideau-Andersen - Botulinum Toxin Therapy, 2020 - Springer
Botulinum neurotoxins (… protein receptor (SNARE) proteins in neurons prevents the release
of neurotransmitters, thus resulting in the muscle paralysis that is characteristic of botulism. …

Botulinum neurotoxin inhibitor binding dynamics and kinetics relevant for drug design

KB Patel, O Kononova, S Cai, V Barsegov… - … et Biophysica Acta (BBA …, 2021 - Elsevier
… for designing a molecule to enhance the efficiency of the inhibition against the neurotoxic
BoNTs are 150 kDa proteins consisting of two chains linked through a disulfide bond. The …

Crystal structure of botulinum neurotoxin type A and implications for toxicity

DB Lacy, W Tepp, AC Cohen, BR DasGupta… - Nature structural …, 1998 - nature.com
… and seven serotypes of botulinum neurotoxin (BoNT/A–BoNT/G). Botulinum neurotoxin
serotype A is synthesized in Clostridium botulinum as a ~150,000 M r single chain protein (1,296 …